Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seonaid Nolan

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Journal of General Internal Medicine|February 27, 2024
Post-hospitalization Care Transition Strategies for Patients with Substance Use Disorders: A Narrative Review and TaxonomyMichael A Incze, A Taylor Kelley, Hannah James, et al.
Journal of Addiction Medicine|March 7, 2020
Factors Associated With the Use of Supervised Consumption Facilities Among Women Who Inject Drugs in a Canadian SettingSarah Ickowicz, Cameron Grant, Ekaterina Nosova, et al.
Journal of Addiction Medicine|March 27, 2025
Uptake of Low-dose Buprenorphine Initiation and Associated Patient Characteristics in British Columbia, Canada: A Population-based Cohort StudyNikki Bozinoff, Jingxin Lei, Tamara Mihic, et al.
AIDS and Behavior|April 16, 2022
Crack cocaine use frequency is associated with HIV disease severity independent of antiretroviral therapy exposure: a prospective cohort studyAlexandria Macmadu, Hudson Reddon, Brandon D L Marshall, et al.
The International Journal on Drug Policy|September 1, 2021
Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housingMiriam Th Harris, Rebecca K Seliga, Nadia Fairbairn, et al.
AIDS Care|April 12, 2011
Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian settingSeonaid Nolan, M-J Milloy, Ruth Zhang, et al.
Addiction Science & Clinical Practice|June 6, 2025
Evaluation of a hospital-based opioid stewardship program on high-risk opioid prescribing in a Canadian setting: an interrupted time series analysisLianping Ti, Tamara Mihic, Arielle Beauchesne, et al.
Drug and Alcohol Dependence|November 13, 2019
Receipt of opioid agonist treatment halves the risk of HIV-1 RNA viral load rebound through improved ART adherence for HIV-infected women who use illicit drugsJoëlla W Adams, Brandon D L Marshall, Nur Afiqah Mohd Salleh, et al.
Substance Abuse Treatment, Prevention, and Policy|February 27, 2016
Factors associated with inability to access addiction treatment among people who inject drugs in Vancouver, CanadaAmy Prangnell, Ben Daly-Grafstein, Huiru Dong, et al.
Journal of Addictive Diseases|June 21, 2022
Factors associated with patient perceived suboptimal dosing of in-hospital opioid agonist therapy among people who use illicit drugs in Vancouver, CanadaSaif-El-Din El-Akkad, Seonaid Nolan, Kanna Hayashi, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Journal of General Internal Medicine|February 27, 2024
Post-hospitalization Care Transition Strategies for Patients with Substance Use Disorders: A Narrative Review and TaxonomyMichael A Incze, A Taylor Kelley, Hannah James, et al.
Journal of Addiction Medicine|March 7, 2020
Factors Associated With the Use of Supervised Consumption Facilities Among Women Who Inject Drugs in a Canadian SettingSarah Ickowicz, Cameron Grant, Ekaterina Nosova, et al.
Journal of Addiction Medicine|March 27, 2025
Uptake of Low-dose Buprenorphine Initiation and Associated Patient Characteristics in British Columbia, Canada: A Population-based Cohort StudyNikki Bozinoff, Jingxin Lei, Tamara Mihic, et al.
AIDS and Behavior|April 16, 2022
Crack cocaine use frequency is associated with HIV disease severity independent of antiretroviral therapy exposure: a prospective cohort studyAlexandria Macmadu, Hudson Reddon, Brandon D L Marshall, et al.
The International Journal on Drug Policy|September 1, 2021
Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housingMiriam Th Harris, Rebecca K Seliga, Nadia Fairbairn, et al.
AIDS Care|April 12, 2011
Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian settingSeonaid Nolan, M-J Milloy, Ruth Zhang, et al.
Addiction Science & Clinical Practice|June 6, 2025
Evaluation of a hospital-based opioid stewardship program on high-risk opioid prescribing in a Canadian setting: an interrupted time series analysisLianping Ti, Tamara Mihic, Arielle Beauchesne, et al.
Drug and Alcohol Dependence|November 13, 2019
Receipt of opioid agonist treatment halves the risk of HIV-1 RNA viral load rebound through improved ART adherence for HIV-infected women who use illicit drugsJoëlla W Adams, Brandon D L Marshall, Nur Afiqah Mohd Salleh, et al.
Substance Abuse Treatment, Prevention, and Policy|February 27, 2016
Factors associated with inability to access addiction treatment among people who inject drugs in Vancouver, CanadaAmy Prangnell, Ben Daly-Grafstein, Huiru Dong, et al.
Journal of Addictive Diseases|June 21, 2022
Factors associated with patient perceived suboptimal dosing of in-hospital opioid agonist therapy among people who use illicit drugs in Vancouver, CanadaSaif-El-Din El-Akkad, Seonaid Nolan, Kanna Hayashi, et al.
Pageof 12